BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18697392)

  • 1. Acyclovir susceptibility of herpes simplex virus isolates at King Chulalongkorn Memorial Hospital, Bangkok.
    Sangdara A; Bhattarakosol P
    J Med Assoc Thai; 2008 Jun; 91(6):908-12. PubMed ID: 18697392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
    Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
    Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
    J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
    Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
    Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues.
    Weinberg A; Leary JJ; Sarisky RT; Levin MJ
    J Clin Virol; 2007 Feb; 38(2):139-45. PubMed ID: 17169605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratypic variations among Thai herpes simplex virus (HSV) isolates determined by restriction fragment length polymorphism (RFLP) analysis.
    Visaprom S; Chindamporn A; Chantratita W; Bhattarakosol P
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):910-6. PubMed ID: 16295545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
    Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
    Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
    Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
    J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of non toxic doses of acyclovir on nitric oxide and cellular death responses in herpesvirus types 1 and 2 infected hep-2 cells.
    Baskin H; Yazici Z; Baskin Y; Olgun N; Ozkul A; Bahar IH
    New Microbiol; 2005 Jul; 28(3):205-13. PubMed ID: 16240692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
    J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
    Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
    J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
    Burrel S; Aime C; Hermet L; Ait-Arkoub Z; Agut H; Boutolleau D
    Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
    Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
    J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2.
    Tardif KD; Jorgensen S; Langer J; Prichard M; Schlaberg R
    J Clin Virol; 2014 Nov; 61(3):382-6. PubMed ID: 25204613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.